Showing 15 posts of 320 posts found.

FDA gives emergency authorisation to first coronavirus tests

March 17, 2020
Manufacturing and Production, Sales and Marketing FDA, Roche, US, coronavirus

The coronavirus crisis in the US has thus far been characterised by a lack of testing within its population. This …


Trump tried to solicit US-exclusivity for coronavirus vaccine, report claims

March 16, 2020
Sales and Marketing CureVac, Trump, US, coronavirus, pharma

President Trump has attracted criticism from all sides over his response to the novel coronavirus outbreak; after repeatedly downplaying the …


FDA halts overseas inspections over coronavirus concerns

March 11, 2020
Research and Development, Sales and Marketing FDA, US, approvals, pharma

The FDA has responded to the ongoing COVID-19 coronavirus outbreak by announcing that it will halt all inspections of overseas …


Acacia Pharma secures first FDA approval with Barhemsys for postoperative nausea and vomiting

February 28, 2020
Medical Communications, Sales and Marketing Acacia, FDA, UK, US, pharma

UK-based Acacia Pharma has secured its first US approval with the FDA’s decision to authorise Barhemsys (amisulpride injection) for the …


US Judge rules that a decade of unpublished trial results must be made public

February 27, 2020
Medical Communications, Research and Development FDA, US, clinical trials, pharma

A federal judge in New York’s Southern District has ruled that 10 years of unpublished clinical trial data must now …


First US coronavirus trial launched into Gilead’s remdesivir

February 26, 2020
Research and Development FDA, Gilead, US, coronavirus, pharma

The first US clinical trial investigating a treatment for the COVID-19 coronavirus has been launched by the US National Institute …


US domestic supply of 150 drugs under threat from coronavirus outbreak

February 25, 2020
Manufacturing and Production MERS, Sars, US, US Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus

Disruption to the US drug production pipeline from the coronavirus could hurt its domestic supply of 150 drugs. US senators …


Read the January/February 2020 edition of Pharmafocus online now!

January 30, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, US, brexit, coronavirus, opioid crisis, pharma

Pharmafocus returns for the New Year with its January/February issue, and things have certainly changed since we left. Brexit got …


New NAFTA terms put hold on Canadian drug prices

December 11, 2019
Research and Development, Sales and Marketing Canada, NAFTA, US, pharma

NAFTA members have agreed to remove a provision that would have increased protections on biologics drugs. This means Canada, despite …


Top Ten most popular articles on this week

November 29, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boris Johnson, Jeremy Corbyn, NHS, Opiod, US, opiod crisis

The NHS was featured heavily in the news this week. Jeremy Corbyn revealed documents detailing previous UK-US discussions in which …


Corbyn reveals documents showing US-UK meetings on deregulating NHS drug pricing

November 27, 2019
Research and Development, Sales and Marketing Jeremy Corbyn, Labour Party, NHS, US, pharma

Labour Leader Jeremy Corbyn has showed off documents that detail secret trade meetings between the US and UK Governments, where …


Lilly to boost Indianapolis manufacturing site with $400m injection, 100 jobs to be created

November 20, 2019
Manufacturing and Production, Research and Development Eli Lilly, US, pharma

Eli Lilly is poised to boost its manufacturing capacity with the investment of $400 million at its Lilly Technology Center …


Amgen poised to cut 172 positions across US, including California HQ

November 19, 2019
Manufacturing and Production Amgen, US, pharma

As revealed in correspondence with the California Employment Development Department, Amgen plans to axe 172 staff positions across the US, …


Donald Trump nominates Dr Stephen Hahn as next FDA Commissioner

November 4, 2019
Medical Communications, Sales and Marketing Donald Trump, FDA, Ned Sharpless, President trump, Scott Gottlieb, Trump, US

The US FDA could be set to receive its next long-term Commissioner after the White House revealed President Donald Trump’s …


2019 saw the FDA approve more generic drugs than ever before

October 18, 2019
Medical Communications, Sales and Marketing FDA, US, generic drugs, pharma

Fiscal year 2019 was a record-breaking one, according to the FDA. The US regulator smashed its previous total for annual …

Latest content